| Neoplasm of Uncertain Histogenesis investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 410show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 732 trials (188 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 732 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 599 trials (119 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 599 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 589 trials (148 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 589 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 347 trials (144 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 347 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 311 trials (193 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 311 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 306 trials (48 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 306 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 276 trials (97 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 276 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 269 trials (65 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 269 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 253 trials (45 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 253 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 242 trials (86 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 242 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 238 trials (39 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 238 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 233 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 233 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 216 trials (56 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 216 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 210 trials (22 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 210 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 203 trials (62 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 203 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 200 trials (89 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 200 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 197 trials (73 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 197 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 186 trials (51 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 186 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 186 trials (80 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 186 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 185 trials (62 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 185 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 180 trials (37 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 180 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 179 trials (50 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 179 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 169 trials (39 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 169 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 159 trials (42 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 159 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 156 trials (40 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 156 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 149 trials (57 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 149 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 148 trials (26 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 148 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 145 trials (26 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 145 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 142 trials (61 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 142 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 115 trials (30 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 115 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 111 trials (34 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 111 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 109 trials (33 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 109 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 101 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 101 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 100 trials (35 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 100 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 93 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 93 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 89 trials (54 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 87 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 87 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 85 trials (24 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 85 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 81 trials (43 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 81 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 80 trials (19 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 79 trials (44 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 79 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemtuzumab Ozogamicinadc 78 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 76 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 76 trials (35 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 75 trials (29 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 75 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 74 trials (33 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 73 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 72 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 70 trials (21 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 68 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 67 trials (36 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 65 trials (19 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 64 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 64 trials (32 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 63 trials (22 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 58 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 54 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 54 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 53 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 52 trials (37 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 51 trials (30 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 51 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 50 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gilteritinibsmall molecule 48 trials (24 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 47 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 47 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 45 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 45 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 43 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 42 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 42 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 41 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 40 trials (28 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 37 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 35 trials (16 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 33 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 31 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Quizartinibsmall molecule 30 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 30 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 29 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Midostaurinsmall molecule 28 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 27 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 26 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ivosidenibsmall molecule 26 trials (21 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 26 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 26 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 25 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 25 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 25 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 24 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 24 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 24 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 24 trials (17 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 21 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 21 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 21 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 20 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 20 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Revumenibsmall molecule 20 trials (17 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 19 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 19 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 18 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 18 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 18 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 18 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 18 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 18 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 17 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinutuximabmonoclonal antibody 16 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 16 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 16 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Omacetaxine Mepesuccinatesmall molecule 16 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 15 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 15 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 15 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 14 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 14 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 12 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 11 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ziftomenibsmall molecule 11 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 9 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 9 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glasdegibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nedaplatinsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Donor Lymphocyte Infusion 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olutasidenibsmall molecule 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amsacrinesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm of Uncertain Histogenesis | 6 | Observed | clinicaltrials | graph → |